Abstract
Background and Objectives: Primary resection and debulking of liver metastases have been associated with improved survival in pancreatic neuroendocrine tumors (PNETs). The treatment patterns and outcomes differences between low-volume (LV) institutions and high-volume (HV) institutions remains unstudied. Methods: A statewide cancer registry was queried for patients with nonfunctional PNET from 1997 to 2018. LV institutions were defined as treating <5 newly diagnosed patients with PNET per year, while HV institutions treated ≥5. Results: We identified 647 patients: 393 with locoregional (n = 236 HV care, n = 157 LV care) and 254 with metastatic disease (n = 116 HV care, n = 138 LV care). Patients with HV care had improved disease-specific survival (DSS) compared to patients with LV care for both locoregional (median 63 vs. 32 months, p < 0.001) and metastatic disease (median 25 vs. 12 months, p < 0.001). In patients with metastatic disease, primary resection (hazard ratio [HR]: 0.55, p = 0.003) and HV institution (HR: 0.63, p = 0.002) were independently associated with improved DSS. Furthermore, diagnosis at a HV center was independently associated with higher odds of receiving primary site surgery (odds ratio [OR]: 2.59, p = 0.01) and metastasectomy (OR: 2.51, p = 0.03). Conclusions: Care at HV centers is associated with improved DSS in PNET. We recommend referral of all patients with PNETs to HV centers.
Original language | English (US) |
---|---|
Pages (from-to) | 956-965 |
Number of pages | 10 |
Journal | Journal of surgical oncology |
Volume | 127 |
Issue number | 6 |
DOIs | |
State | Published - May 2023 |
Keywords
- metastasectomy
- referral center
- referral patterns
- survival
- treatment patterns
ASJC Scopus subject areas
- Surgery
- Oncology